Advertisement

Picture Berlin Partner Bionnale 2021 Digital Event 650x80px
Organisation › Details

Scienion (Group)

SCIENION offers complete solutions for precise liquid dispensing applications enabling high throughput production of multiparameter assays in diagnostics, and life and material sciences. Addressing the dynamically increasing needs for miniaturization and multiplex analyses, SCIENION offers a unique technology portfolio that has been continuously expanded for almost 20 years. SCIENION provides flexible solutions for research and development, wherein solutions for production purposes are customized. Systems and software are characterized by their versatility, precision and robustness. The company is a renowned specialist for ultra-low volume liquid handling, particularly for the handling of precious and sensitive compounds of biological or chemical origin. SCIENION’s dispensers allow for contact-free and precise drop spotting in the pico-liter to micro-liter range and are optimally suited for microarray based analytics – such as for tests with DNA, oligonucleotides, peptides, proteins, antibodies, glycans or for dispensing cells onto various substrates. The company operates from two sites in Germany, Dortmund and Berlin, and has subsidiaries in Phoenix, Arizona, USA, Lyon, France and Chichester, UK. Since August 2020, SCIENION is a CELLINK company. CELLINK is the leading bio-convergence company and a global provider of technologies, products and services to create, understand and master biology. *

 

Period Start 2000-12-01 splitoff
  Group Scienion AG
  Today Scienion AG, Berlin
  Predecessor Max Planck Institute for Molecular Genetics (MPI-MG) (Berlin)
Product Industry biochip system
     
Region Region Berlin
  Country Germany
  Street 7b Volmerstr.
  City 12489 Berlin
  Tel +49-30-6392-1700
    Address record changed: 2020-12-02
     
Basic data Employees B: 11 to 50 (2017-09-07)
  Currency EUR
  Annual sales 21,500,000 (revenue (2019) 2019-12-31)
     
    * Document for �About Section�: Boehringer Ingelheim. (12/18/20). "Press Release: New SARS-CoV-2 Neutralizing Antibody Enters Clinical Phase". Cologne, Marburg, Braunschweig & Ingelheim.
     
   
Record changed: 2021-02-17

Advertisement

Picture Berlin Partner Berlin-Brandenburg Healthcare Industries Cluster 650x80px

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture EBD Group Global Partnering Four Events One Price 650x80




» top